Maria N Boshra, Hossam M Moharram, Yehia M Khairat, M Tarek A Moustafa
{"title":"Quantifying pupillary dilation-induced alterations in intraocular pressure, angle, and anterior segment parameters in pseudoexfoliation syndrome using Scheimpflug imaging.","authors":"Maria N Boshra, Hossam M Moharram, Yehia M Khairat, M Tarek A Moustafa","doi":"10.4103/ojo.ojo_159_24","DOIUrl":"10.4103/ojo.ojo_159_24","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of the study is to compare the effects of three mydriatic agents on anterior segment parameters and intraocular pressure (IOP) in pseudoexfoliation (PEX) patients and compare the results with healthy controls.</p><p><strong>Patients and methods: </strong>This cross-sectional study involved 25 PEX and 16 control patients. Each received three dilating drops (phenylephrine, tropicamide, and cyclopentolate) with eye examinations before and after (over 3 weeks). The measured parameters included IOP, gonioscopy grading, and Scheimpflug imaging analysis of anterior chamber depth, anterior chamber volume, anterior chamber angle, pupillary diameter (PD), central corneal thickness (CCT), and corneal volume.</p><p><strong>Results: </strong>The mean age was 66.12 years in the PEX group and 55 years in the control group. There were no significant differences between the groups in baseline parameters, except for CCT being significantly thicker in the control group (<i>P</i> = 0.049). After 2 h of using the dilating drops, the PEX group showed no change in CCT and gonioscopy measurement while all the other tested parameters showed a significant increase. Phenylephrine caused the greatest increase in pupil diameter. Correlation analysis of PD versus other parameters in both groups showed only a negative significant correlation between PD and IOP when using tropicamide on the PEX patients.</p><p><strong>Conclusion: </strong>All three dilating drops are effective in dilating PEX patients. Phenylephrine is the most effective and ideal for both clinics and surgeries. Cyclopentolate is the least effective dilator in PEX patients compared to healthy controls. Tropicamide 1% provides a good balance between pupil dilation and minimal IOP elevation, making it safer for PEX patients.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"18 1","pages":"33-39"},"PeriodicalIF":0.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Selim Doganay, Mehmet Omer Kiristioglu, Gamze Ucan Gunduz
{"title":"A novel surgical technique: \"Ab interno\" autologous lamellar scleral patch for a large traumatic scleral defect at the posterior pole.","authors":"Selim Doganay, Mehmet Omer Kiristioglu, Gamze Ucan Gunduz","doi":"10.4103/ojo.ojo_104_24","DOIUrl":"10.4103/ojo.ojo_104_24","url":null,"abstract":"<p><p>This case report presents the case of a 60-year-old man who underwent autologous lamellar scleral patch graft (SPG) repair for a large posterior pole scleral defect during pars plana vitrectomy (PPV). Initially, the patient experienced a perforating air rifle pellet injury, necessitating suturing of the entry wound. Six days later, lensectomy and PPV were performed for traumatic cataract, removal of an intraocular foreign body, dense vitreous hemorrhage, and retinal detachment. During PPV, a significant full-thickness scleral defect was found at the posterior pole and repaired using a 3.5 mm × 4.5 mm autologous lamellar SPG sourced from the superotemporal superficial sclera. Postoperatively, the graft fully adhered to the adjacent sclera without complications such as silicone oil leakage or inflammation. This case marks the first instance of utilizing an autologous lamellar SPG for such a large posterior pole defect during PPV, showcasing its effectiveness and safety for such challenging conditions.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"18 1","pages":"77-80"},"PeriodicalIF":0.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical outcome of eplerenone in the management of acute central serous chorioretinopathy.","authors":"Pramod Kumar Sharma, Bhagyashree Padhan, Ipsita Khuntia, Madhumita Naik, Biswambara Satpathy","doi":"10.4103/ojo.ojo_118_23","DOIUrl":"10.4103/ojo.ojo_118_23","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the clinical outcomes of eplerenone in the management of acute central serous chorioretinopathy (CSCR).</p><p><strong>Materials and methods: </strong>This case-control study involved 52 eyes of 52 cases of acute CSCR divided between treatment (26) and control (26) groups. Cases in the treatment group were managed by tablet eplerenone 50 mg/d. During the scheduled visits, serum electrolytes and an ophthalmic evaluation, including optical coherence tomography, were conducted. The control group was subject to observation and a similar follow-up. The Statistical Programme for Social Sciences, version 23 was used for statistical tests.</p><p><strong>Results: </strong>The mean age in the treatment and control group was 39.15 ± 12.1 years and 36.1 ± 8.09 years, respectively. In the treatment group, 46.15% of right eyes and 53.8% of left eyes, and in the control group, 61.5% of right eyes and 38.5% of left eyes were evaluated. Visual acuity improved to 6/6 in 96.2% of treated cases and 19.2% of controls in the 2<sup>nd</sup> month of follow-up. Subretinal fluid resolved completely in 61.52% of treated cases and 38.46% of controls at 12-week follow-up. No adverse events were reported, and by the 12<sup>th</sup> week of follow-up, the mean serum K+ was 4.80 ± 0.157 mEq/L.</p><p><strong>Conclusion: </strong>Acute CSCR cases managed with oral eplerenone can attain faster resolution with significant functional improvement. Eplerenone may serve as a first-line therapeutic option for acute CSCR with a better safety profile.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"18 1","pages":"9-15"},"PeriodicalIF":0.0,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ewelina Niedzwiecka, Julio Cesar Molina Martín, Juan García Sánchez, Violeta Martínez Torres, Encarnación Mengual Verdú
{"title":"Foveal adhesion of a dexamethasone implant: Evaluation and follow-up via multimodal imaging.","authors":"Ewelina Niedzwiecka, Julio Cesar Molina Martín, Juan García Sánchez, Violeta Martínez Torres, Encarnación Mengual Verdú","doi":"10.4103/ojo.ojo_297_23","DOIUrl":"10.4103/ojo.ojo_297_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"411-412"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"\"Headlight in the fog\" fundus appearance: Is just a sign and not a conclusion.","authors":"Krushna Gopal Panda, Anup Kelgaonkar","doi":"10.4103/ojo.ojo_204_23","DOIUrl":"10.4103/ojo.ojo_204_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"405-407"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparing the sedative and analgesic effects of ketorolac and diclofenac eye drops among patients with cataract surgery: A double-blind randomized clinical trial.","authors":"Hesameddin Modir, Esmail Moshiri, Alireza Amani, Amirreza Modir","doi":"10.4103/ojo.ojo_246_23","DOIUrl":"10.4103/ojo.ojo_246_23","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to compare the sedative and analgesic effects of ketorolac and diclofenac eye drops among patients with cataract surgery (CS) who received tetracaine.</p><p><strong>Methods: </strong>This double-blind randomized clinical trial was conducted in 2022. Participants were the candidates for CS consecutively selected from Amirkabir hospital, Arak, Iran, and were assigned to an artificial tear group, a ketorolac group, and a diclofenac group through block randomization. Pain, sedation status, heart rate, blood pressure, and arterial oxygen saturation were assessed during and after surgery. Complications prevalence and intraoperative propofol use were also documented. Data were analyzed using the SPSS software (v. 20.0) at a significance level of <0.05.</p><p><strong>Results: </strong>There were no significant differences among the study groups respecting participants' age, gender, body mass index, blood pressure, heart rate, arterial oxygen saturation, CS duration, and Aldrete score (<i>P</i> > 0.05). From 5 min after CS onward, the mean score of pain in the ketorolac group was significantly less than the other groups (<i>P</i> < 0.05). The mean score of sedation from recovery to 1 h after surgery in the artificial tear group was significantly more than the other groups, whereas the mean score of sedation 2 and 4 h after CS in the ketorolac group was significantly more than the other groups (<i>P</i> < 0.05). Propofol use in the artificial tear group was significantly more than in other groups (<i>P</i> = 0.001) and patient and surgeon satisfaction in this group was significantly less than in other groups (<i>P</i> < 0.05). The ketorolac and the diclofenac groups did not significantly differ from each other respecting surgeon and patient satisfaction and the prevalence of complications (<i>P</i> > 0.05).</p><p><strong>Conclusion: </strong>Ketorolac eye drops are more effective than diclofenac eye drops in significantly reducing intraoperative pain among the candidates for CS with topical anesthesia. Therefore, ketorolac eye drops can be used with tetracaine eye drops in CS with topical anesthesia to produce greater perioperative analgesia and sedation.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"342-347"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Branch retinal artery occlusion in a young patient with Mayer-Rokitansky-Küster-Hauser type 2 syndrome.","authors":"Anita Bedwal, Mousumi Banerjee, Parveen Rewri","doi":"10.4103/ojo.ojo_48_24","DOIUrl":"10.4103/ojo.ojo_48_24","url":null,"abstract":"<p><p>Retinal vascular occlusions are rare in young people, and any occlusion warrants an extensive clinical evaluation to establish the etiology. Cardiac malformations are a source of embolism. We present a case of atrial septal defect (ASD) in a patient with type II Mayer-Rokitansky-Küster-Hauser syndrome, leading to unilateral branch retinal arterial occlusion (BRAO) in a young woman. A 21-year-old woman presented with sudden, painless, blurring of vision, and a superior visual field defect in her right eye. A fundus examination confirmed the BRAO diagnosis. Ocular and systemic evaluation revealed primary amenorrhea, ASD, ectopic kidneys, and pelvic cyst. Any vascular occlusion in a young patient must be thoroughly evaluated, including a detailed systemic history.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"393-395"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}